Shandong Linuo Pharmaceutical Packaging Co., Ltd. (SHE:301188)
China · Delayed Price · Currency is CNY 26.28
+0.30 (1.15%)
May 7, 2026, 3:14 PM CST
SHE:301188 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,026 | 981.47 | 1,055 | 924.39 | 767.42 | 881.32 |
Other Revenue | - | - | 25.73 | 22.97 | 54.6 | 7.56 |
| 1,026 | 981.47 | 1,081 | 947.37 | 822.02 | 888.88 | |
Revenue Growth (YoY) | -5.90% | -9.19% | 14.09% | 15.25% | -7.52% | 34.67% |
Cost of Revenue | 805.28 | 774.14 | 884.89 | 787.73 | 646.56 | 670.42 |
Gross Profit | 220.28 | 207.34 | 195.95 | 159.64 | 175.47 | 218.46 |
Selling, General & Admin | 119.44 | 114.16 | 87.03 | 67.7 | 49.69 | 49.81 |
Research & Development | 34.37 | 34.37 | 33.8 | 30.13 | 25.96 | 32.5 |
Other Operating Expenses | -9.55 | -11.66 | 2.59 | 2.61 | 5.79 | 6.29 |
Operating Expenses | 144.25 | 136.86 | 124.73 | 102.68 | 81.48 | 90.95 |
Operating Income | 76.03 | 70.48 | 71.22 | 56.96 | 93.99 | 127.51 |
Interest Expense | - | - | -25.81 | -9.04 | - | -0.99 |
Interest & Investment Income | 11.38 | 10.86 | 18.59 | 16.27 | 15.04 | 6.21 |
Currency Exchange Gain (Loss) | - | - | 2.04 | -0.02 | 5.62 | -2.2 |
Other Non Operating Income (Expenses) | -26.58 | -27.73 | -0.56 | -0.85 | 0.44 | -0.07 |
EBT Excluding Unusual Items | 60.82 | 53.6 | 65.49 | 63.33 | 115.08 | 130.45 |
Gain (Loss) on Sale of Investments | 1.4 | 1.67 | 1.45 | 2.15 | 1.35 | - |
Gain (Loss) on Sale of Assets | 2.4 | 2.4 | 0.03 | 0.05 | 0.47 | 0.45 |
Asset Writedown | -9.73 | -8.45 | -0.65 | -0.05 | -0.01 | -0.07 |
Other Unusual Items | - | - | 5.13 | 7.33 | 9.83 | 9.45 |
Pretax Income | 54.89 | 49.22 | 71.45 | 72.81 | 126.72 | 140.27 |
Income Tax Expense | 14.75 | 9.56 | 5.38 | 6.89 | 10.07 | 15.49 |
Net Income | 40.14 | 39.66 | 66.07 | 65.92 | 116.65 | 124.78 |
Net Income to Common | 40.14 | 39.66 | 66.07 | 65.92 | 116.65 | 124.78 |
Net Income Growth | -50.92% | -39.97% | 0.23% | -43.49% | -6.51% | 37.42% |
Shares Outstanding (Basic) | 234 | 233 | 228 | 235 | 233 | 178 |
Shares Outstanding (Diluted) | 234 | 233 | 228 | 235 | 233 | 178 |
Shares Change (YoY) | 1.28% | 2.40% | -3.23% | 0.91% | 30.88% | 2.08% |
EPS (Basic) | 0.17 | 0.17 | 0.29 | 0.28 | 0.50 | 0.70 |
EPS (Diluted) | 0.17 | 0.17 | 0.29 | 0.28 | 0.50 | 0.70 |
EPS Growth | -51.54% | -41.38% | 3.57% | -44.00% | -28.57% | 34.62% |
Free Cash Flow | -318.07 | -306.5 | -86.55 | -52.04 | -115.99 | -20.91 |
Free Cash Flow Per Share | -1.36 | -1.31 | -0.38 | -0.22 | -0.50 | -0.12 |
Dividend Per Share | - | - | 0.100 | 0.100 | 0.200 | 0.200 |
Dividend Growth | - | - | - | -50.00% | - | - |
Gross Margin | 21.48% | 21.13% | 18.13% | 16.85% | 21.35% | 24.58% |
Operating Margin | 7.41% | 7.18% | 6.59% | 6.01% | 11.43% | 14.34% |
Profit Margin | 3.91% | 4.04% | 6.11% | 6.96% | 14.19% | 14.04% |
Free Cash Flow Margin | -31.01% | -31.23% | -8.01% | -5.49% | -14.11% | -2.35% |
EBITDA | 208.25 | 197.34 | 176.62 | 139.55 | 159.27 | 182.64 |
EBITDA Margin | 20.31% | 20.11% | 16.34% | 14.73% | 19.38% | 20.55% |
D&A For EBITDA | 132.22 | 126.86 | 105.4 | 82.59 | 65.28 | 55.14 |
EBIT | 76.03 | 70.48 | 71.22 | 56.96 | 93.99 | 127.51 |
EBIT Margin | 7.41% | 7.18% | 6.59% | 6.01% | 11.43% | 14.34% |
Effective Tax Rate | 26.87% | 19.42% | 7.53% | 9.46% | 7.94% | 11.04% |
Revenue as Reported | - | - | 1,081 | 947.37 | 822.02 | 888.88 |
Advertising Expenses | - | - | 4.42 | 2.72 | 0.33 | 0.58 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.